D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 30,395 453 World Ranking 9094 National Ranking 4838

Research.com Recognitions

Awards & Achievements

2020 - Fellow of the Royal Society of Canada Academy of Social Sciences

1934 - Fellow of the American Association for the Advancement of Science (AAAS)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Internal medicine, Oncology, Cancer research, Childhood Acute Lymphoblastic Leukemia and Acute lymphocytic leukemia are his primary areas of study. His Immunology research extends to Internal medicine, which is thematically connected. His work deals with themes such as Methotrexate, Clinical trial, Multivariate analysis, Asparaginase and Prednisone, which intersect with Oncology.

His research integrates issues of Gene rearrangement, Genome-wide association study, Gene expression profiling, Mutation and Tyrosine kinase in his study of Cancer research. His work carried out in the field of Childhood Acute Lymphoblastic Leukemia brings together such families of science as Mercaptopurine, Disease and Acute leukemia. His Acute lymphocytic leukemia study which covers Cancer that intersects with Precision medicine, Family medicine, Pathology and Alternative medicine.

His most cited work include:

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. (995 citations)
  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (737 citations)
  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (737 citations)

What are the main themes of his work throughout his whole career to date?

William L. Carroll focuses on Internal medicine, Oncology, Acute lymphocytic leukemia, Leukemia and Cancer research. His Internal medicine study often links to related topics such as Cog. The study incorporates disciplines such as Cancer, Methotrexate, Immunology, Childhood Acute Lymphoblastic Leukemia and Prednisone in addition to Oncology.

His Immunology research includes themes of Allele and Drug resistance. His Acute lymphocytic leukemia research incorporates themes from Gene expression profiling, Regimen, Vincristine, Hematology and Single-nucleotide polymorphism. His studies examine the connections between Cancer research and genetics, as well as such issues in Mutation, with regards to Molecular biology.

He most often published in these fields:

  • Internal medicine (56.13%)
  • Oncology (42.65%)
  • Acute lymphocytic leukemia (21.57%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (56.13%)
  • Oncology (42.65%)
  • Leukemia (20.34%)

In recent papers he was focusing on the following fields of study:

William L. Carroll mainly investigates Internal medicine, Oncology, Leukemia, Lymphoblastic Leukemia and Cog. His work in Minimal residual disease, Methotrexate, Young adult, Acute lymphocytic leukemia and Clinical trial is related to Internal medicine. The Acute lymphocytic leukemia study which covers Vincristine that intersects with Mercaptopurine.

William L. Carroll has included themes like Cancer, Childhood Acute Lymphoblastic Leukemia, Randomized controlled trial and Chemotherapy in his Oncology study. His research on Leukemia concerns the broader Immunology. His Lymphoblastic Leukemia study combines topics in areas such as Down syndrome and Pharmacology.

Between 2016 and 2021, his most popular works were:

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia (329 citations)
  • Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. (125 citations)
  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia (105 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

William L. Carroll spends much of his time researching Internal medicine, Oncology, Leukemia, Clinical trial and Cancer research. As part of his studies on Internal medicine, William L. Carroll frequently links adjacent subjects like Cog. His Oncology study combines topics from a wide range of disciplines, such as Survival rate, Young adult, Chemotherapy and Minimal residual disease.

His studies in Leukemia integrate themes in fields like Hematology, Gene, Germline and Drug resistance. He combines subjects such as Thiopurine methyltransferase, Hypodiploid Acute Lymphoblastic Leukemia, Incidence and Pediatrics with his study of Clinical trial. His research in Cancer research focuses on subjects like Mutation, which are connected to DNA mismatch repair.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke.
The New England Journal of Medicine (2009)

1474 Citations

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey.
The New England Journal of Medicine (2014)

1222 Citations

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

Stephen P. Hunger;Xiaomin Lu;Meenakshi Devidas;Bruce M. Camitta.
Journal of Clinical Oncology (2012)

1151 Citations

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

Ching Hon Pui;William L. Carroll;Soheil Meshinchi;Robert J. Arceci.
Journal of Clinical Oncology (2011)

1015 Citations

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Jyoti D. Patel;Lada Krilov;Sylvia Adams;Carol Aghajanian.
Journal of Clinical Oncology (2010)

925 Citations

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman.
Blood (2008)

869 Citations

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton.
Journal of Clinical Oncology (2009)

766 Citations

Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst.
Cancer Cell (2012)

752 Citations

JAK mutations in high-risk childhood acute lymphoblastic leukemia.

Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood.
Proceedings of the National Academy of Sciences of the United States of America (2009)

693 Citations

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton.
Blood (2010)

670 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing William L. Carroll

Ching-Hon Pui

Ching-Hon Pui

St. Jude Children's Research Hospital

Publications: 165

Charles G. Mullighan

Charles G. Mullighan

St. Jude Children's Research Hospital

Publications: 152

Stephen P. Hunger

Stephen P. Hunger

University of Pennsylvania

Publications: 122

Martin Schrappe

Martin Schrappe

Kiel University

Publications: 108

Mary V. Relling

Mary V. Relling

St. Jude Children's Research Hospital

Publications: 96

William E. Evans

William E. Evans

St. Jude Children's Research Hospital

Publications: 88

Giuseppe Basso

Giuseppe Basso

University of Padua

Publications: 87

Rob Pieters

Rob Pieters

Princess Maxima Center for Pediatric Oncology

Publications: 85

Mignon L. Loh

Mignon L. Loh

University of California, San Francisco

Publications: 84

Lewis B. Silverman

Lewis B. Silverman

Harvard University

Publications: 83

Christine J. Harrison

Christine J. Harrison

Newcastle University

Publications: 81

Kjeld Schmiegelow

Kjeld Schmiegelow

University of Copenhagen

Publications: 81

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 78

Andrea Biondi

Andrea Biondi

University of Milano-Bicocca

Publications: 70

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 62

Shai Izraeli

Shai Izraeli

Tel Aviv University

Publications: 57

Trending Scientists

William Regli

William Regli

University of Maryland, College Park

Yi Pan

Yi Pan

Shenzhen Institutes of Advanced Technology

Gerwin Schalk

Gerwin Schalk

Fudan University

Fernando Pirani

Fernando Pirani

University of Perugia

Stephen R. Baillie

Stephen R. Baillie

British Trust for Ornithology

K. Eric Wommack

K. Eric Wommack

University of Delaware

François Gros

François Gros

Collège de France

Veerle Fievez

Veerle Fievez

Ghent University

Robert Niven

Robert Niven

University of Manchester

Perry Bartelt

Perry Bartelt

Swiss Federal Institute for Forest, Snow and Landscape Research

Warren T. Blume

Warren T. Blume

University of Western Ontario

Jean-Philippe Laurenceau

Jean-Philippe Laurenceau

University of Delaware

Paul Calès

Paul Calès

University of Angers

Daniel J. Schaid

Daniel J. Schaid

Mayo Clinic

David M. Ceperley

David M. Ceperley

University of Illinois at Urbana-Champaign

Something went wrong. Please try again later.